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Abstract No. 85 
Objectives: The type 1 cannabinoid receptor (CB1R) is highly expressed in homeostatic and 
reward areas, which have key roles in regulating energy balance and feeding behaviour, and 
hence in weight gain and obesity. We investigated whether regional CB1R availability and body 
mass index (BMI) are differentially associated in subjects with disorders of food intake (DFI; 
anorexia nervosa [AN], bulimia nervosa [BN], functional dyspepsia with severe weight loss 
[FD], and obesity [OB]) from healthy controls (CON). 
Methods: A total of 80 subjects with a large BMI range were scanned using [18F]MK-9470. 
Fifty-four subjects were DFI patients (14 AN, 16 BN, 12 FD, 12 OB; BMI range = 12.5-40.6 
kg/m2) and 26 CON matched for gender, age, and average BMI (BMI range = 18.5-26.6 kg/m2). 
Correlations were assessed with key homeostatic (hypothalamus, pons, medulla, midbrain) and 
reward (nucleus accumbens, caudate nucleus, putamen, pallidum, orbitofrontal cortex, insula, 
amygdala) regions of interest (P<0.05 Stepdown-Bonferroni correction) and voxel-based 
analyses (SPM8, PFWE-corrected<0.05). 
Results: In CON, CB1R availability was negatively correlated to BMI mainly in the 
homeostatic regions (all P 0.05 and r>-0.60). Conversely, in DFI subjects, the negative 
correlation between CB1R availability and BMI was significant in both homeostatic (all P<2.1e
-
04 and r -0.54) and reward-related regions (all P<2.8e-04 and r -0.51). 
Conclusions: Both the control and DFI groups showed a correlation with higher BMI having 
decreased CB1R availability in homeostatic regions, playing a role in the control of energy 
homeostasis. However, in DFI subjects, the negative correlation was also present in the 
mesolimbic reward circuitry, which could result in inappropriate food intake and attribution of 
incentive value to food and hence result in either under- or overweight. 
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